Belinda Campbell

Delighted to be part of this excellent EORTC series! Join us on Jan 20th 5pm CET (that’s Jan 21st 3am AEDT🇦🇺). I’ll be talking about #RT for the more rare #CTCL subtypes. ⬇️Register⬇️ 🙏to @DrKhaledElsayad & @EORTC. @PeterMacCC @ILROGTeam @AustralasianLy1 @TargetingCancer

Congrats to Prof Karin (Kas) Thursky and team on the launch of the new Centre for Health Services Research in Cancer! It will transform cancer care delivery by embedding patient voices, data and system-level innovation into everyday practice. 🔗 petermac.org/about-us/news-…

Hot off the press!! 😁 Large-cell transformation of #MycosisFungoides Published in @BrJHaem Open access➡️doi.org/10.1111/bjh.20… Congrats & 🙏to Dr Martin Higgins & Dr Pippa Johnstone, 2 super⭐️ former #radonc cutaneous lymphoma fellows at @PeterMacCC & joint first authors👏

Geospatial analyses reveal heterogeneity in CTCL incidence across Australia, with lower diagnosis rates in rural/remote and socioeconomically disadvantaged areas, and differing from that of all rare cancers. doi.org/10.1093/bjd/lj…

Love this paper! Brilliant collaboration of clinicians, epidemiologists & health services researchers. Geospatial analyses expose diagnostic disparity in #CTCL across 🇦🇺 Open access ➡️doi.org/10.1093/bjd/lj… 🙏 to truly outstanding co-authors, @MACHAustralia & @BrJDermatol

Amazing whirlwind of health services research presented by @JuliaLaiKwon at the 2025 @PeterMacCC Research Symposium. 👏👏👏 @PeterMacRes @PeterMacHSR

A/Prof Michelle Yong never fails to impress! Thank you, Michelle, for a brilliant & engaging plenary presentation at the 2025 @PeterMacCC Research Symposium. Important research in infection risk & treatment in our immunocompromised patients with #cancer. @michyong2 @PeterMacRes

🔊🔊Last chance to register for tonight. 🔊🔊

Calling all Healthcare Professionals! Join our expert panel for this educational webinar as they explore the recently published Australasian Lymphoma Alliance Consensus Practice Statement. Coming up Thursday 1st May. Details & Registration details here: us06web.zoom.us/webinar/regist…

Calling all Healthcare Professionals! Join our expert panel for this educational webinar as we explore the recently published ALA Consensus Practice Statements. Coming up Thursday 1st May. Details & Registration details here: us06web.zoom.us/webinar/regist…

Check this out! 😃 Clinical-research #fellowships in radiation oncology at @PeterMacCC 🇦🇺 Apply here ➡️ careers.petermac.org/job/MELBOURNE-…

Seminars in Radiation Oncology shares "Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024" by Dr Campbell @belinda_campbe, Dr Prince @MilesPrince4, ....Dr Porceddu sciencedirect.com/science/articl…

📢 Join the third CLTG and ROSC webinar on 20 January from 5 PM - 5:45 PM CET ⏳ Registration closes 17 January 11h. Don’t miss out! 👉 cm.eortc.org/cmPortal/Porta… #RADCUTIS #CancerResearch #ClinicalTrials #Oncology #Cutaneous #Lymphoma #RadiationOncology #Radiotherapy

Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members redjournal.org/video-do/real-…

Y-ECI CLTG and Y-ECI ROSC Webinar Series eortc.org/event/y-eci-cl…

Congrats and 🙏 to @DrKhaledElsayad and #EORTC-CLTG colleagues on this intriguing & topical work exposing the heterogeneity in #RT for #cutaneouslymphomas Open access ➡️ redjournal.org/article/S0360-… @EORTC @IJROBP @MarioLevis82 @LenaSpecht1 @PeterMacCC @RANZCRcollege @ILROGTeam

Congratulations @belinda_campbe - fantastic work in a technically challenging area of #RadOnc 👏👏👏

Delighted to share this mammoth review of #CTCL: barriers to care & current controversies in #RT. Huge thanks to excellent expert co-authors & editors at #SeminarsinRadiationOncology. 🙏 Open Access ➡️ sciencedirect.com/science/articl… @ILROGTeam @PeterMacCC @UniMelb @AustralasianLy1